Immunoglobulin G4-related disease is a complex immune condition that can silently damage multiple organs before patients even realize something is wrong, often masquerading as cancer or other serious illnesses.
What Is Immunoglobulin G4-Related Disease?
Immunoglobulin G4-related disease, commonly known as IgG4-RD, is a chronic immune-mediated condition that affects how the body’s defense system works. Instead of protecting the body properly, the immune system becomes abnormally active and causes inflammation and scarring in various organs. This disease has only been recognized as a distinct condition relatively recently, with much of our understanding developing over the past two decades.[1]
The condition gets its name from immunoglobulin G4, which is a type of antibody normally found in small amounts in the blood. Antibodies are proteins that help the immune system fight infections and other threats. IgG4 is actually the least common of four subtypes of IgG antibodies. In this disease, immune cells that produce IgG4, along with other related cells, accumulate abnormally in certain organs and cause damage.[5]
What makes IgG4-RD particularly challenging is that it can affect virtually any organ in the body. The disease creates tumor-like masses and causes organs to enlarge, which often leads doctors to initially suspect cancer. The organs most commonly involved include the pancreas, kidneys, structures around the eyes, salivary glands, and tissues at the back of the abdomen. However, the lungs, bile ducts, tear glands, aorta, meninges (the layers covering the brain and spinal cord), and thyroid gland can also be affected.[1][2]
Epidemiology: Who Gets IgG4-Related Disease?
The exact number of people affected by IgG4-related disease worldwide is not fully known, making it difficult to establish precise prevalence figures. What is clear is that IgG4-RD is considered a rare condition. In the United States, it has been estimated to affect fewer than 200,000 people, though recent data suggests there may have been over 50,000 cases as of 2024.[1][9]
Unlike most autoimmune diseases, which typically affect more women than men, IgG4-related disease is more common in males. Men are more likely to develop the condition and tend to experience more severe disease with involvement of multiple organs, higher serum IgG4 levels, and greater internal damage. This male predominance is unusual in the world of immune-mediated diseases and remains an interesting characteristic of this condition.[2][13]
The disease most commonly affects middle-aged to older individuals, with the average age of diagnosis around 60 years. However, IgG4-RD does not discriminate by age alone and can affect people across the entire age spectrum. Cases have been documented in children as well as individuals in their 90s. The disease can affect people of every race and ethnicity, with no particular group being immune to its effects.[2][3][13]
Most patients have multiple organs involved at the time of diagnosis, though they typically have one dominant area of disease that causes the most noticeable symptoms. Some patients, however, have disease limited to just one organ. It is not unusual for the disease to affect anywhere between two to six organs simultaneously, which adds to the complexity of diagnosis and treatment.[2][3]
Causes of IgG4-Related Disease
The exact cause of IgG4-related disease remains unknown, which places it among many immune conditions where the triggering factors are still being investigated. Researchers believe that multiple factors likely contribute to the development of this condition rather than a single identifiable cause.[1]
Current scientific thinking suggests that the disease may be related to a person’s genetic background, meaning that some individuals may be born with a predisposition to developing IgG4-RD. However, having genetic susceptibility does not guarantee that someone will develop the disease. Other factors appear to be necessary to trigger the condition in susceptible individuals.[1]
Bacterial infections and a process called molecular mimicry are also thought to play potential roles. Molecular mimicry occurs when the immune system mistakes the body’s own tissues for foreign invaders, such as bacteria or viruses, because they share similar molecular structures. This case of mistaken identity can lead the immune system to attack the body’s own organs. Some researchers have proposed that infections might trigger this confused immune response in people who are genetically susceptible.[1]
The disease is also considered an autoimmune condition, which means it involves the body’s defense system attacking its own tissues. In IgG4-RD, no single disease-specific antibody has been identified that clearly explains the condition. Instead, the damage appears to result from a complex interaction of immune cells, particularly B cells (a type of white blood cell), that accumulate in affected organs and drive inflammation. These B cells are thought to directly cause inflammation and scarring through proteins called cytokines, which affect how the immune system functions.[2][9]
Risk Factors for Developing IgG4-RD
Given that the precise cause of IgG4-related disease is not fully understood, identifying specific risk factors remains challenging. However, certain characteristics appear to be associated with a higher likelihood of developing the condition.
Being male is one of the most clear risk factors for IgG4-RD. Men are not only more likely to develop the disease but also tend to experience more severe manifestations with multiple organ involvement. The reasons for this gender difference are not yet fully understood, but it represents an important epidemiological pattern that distinguishes IgG4-RD from many other autoimmune conditions.[2][13]
Age also plays a role, with middle-aged and older adults being more commonly affected. While the disease can occur at any age, the typical patient is diagnosed around age 60. This suggests that factors associated with aging may contribute to disease development or that the disease requires many years to develop before becoming clinically apparent.[3][13]
Having a genetic predisposition is thought to be another risk factor, though specific genes associated with IgG4-RD have not been definitively identified. Family studies and genetic research are ongoing to better understand the hereditary components of this disease.[1]
Symptoms and How They Affect Patients
The symptoms of IgG4-related disease vary widely depending on which organs are affected, making this a particularly unpredictable condition for patients to live with. Some patients describe feeling as though they must “spin the wheel” each morning to see what symptoms they will face that day. This unpredictability adds a significant emotional and practical burden to living with IgG4-RD.[15]
Many patients experience common symptoms that are not specific to any particular organ. These include swollen lymph nodes, unexplained weight loss, and persistent fatigue. Weight loss is particularly common when multiple organs are involved or when the pancreas does not produce enough digestive enzymes. Importantly, IgG4-RD almost never causes fever, which helps distinguish it from infectious conditions.[5][8]
When IgG4-RD affects the pancreas and bile ducts, patients may develop painless jaundice, which causes the skin and eyes to turn yellow. This occurs when swelling of the pancreas blocks the flow of bile from the liver to the digestive tract. Some people develop acute inflammation of the pancreas, called pancreatitis, which causes severe abdominal pain and nausea. Others develop chronic pancreatitis over time, leading to symptoms such as gas, feeling full quickly, diarrhea, poor nutrition, weight loss, and even diabetes.[5][8]
Disease affecting the retroperitoneal tissues (at the back of the abdomen) may not cause any symptoms at first, or it may cause flank or back pain. The fibrous tissue that develops can compress the tubes that carry urine from the kidneys to the bladder, called ureters, blocking urine flow and potentially damaging the kidneys. When the walls of the aorta (the main blood vessel from the heart) are affected, this can lead to a dangerous bulging called an aortic aneurysm.[5][8]
The salivary and lacrimal (tear) glands are frequently affected in IgG4-RD. When this occurs, patients notice painless swelling on one or both sides of the face, below the chin, or over the outer portion of the upper eyelids. Despite this swelling, dry mouth and dry eyes are actually uncommon in IgG4-RD, which helps distinguish it from similar conditions like Sjögren disease.[2][5]
When IgG4-RD affects the orbits (the structures surrounding the eyes), particularly the muscles that control eye movement, patients may develop bulging eyes, swelling and pain around the eyes, double vision, or pain when moving the eyes. This type of involvement is among the most frequent manifestations of IgG4-RD, observed in almost 20% of cases.[2][3]
Lung involvement may cause no symptoms at all, or patients may experience cough, shortness of breath, or sharp chest pain when breathing in. The pain often results from inflammation of the pleura, which are the thin layers of tissue separating the lungs from the chest wall.[5][8]
Additional symptoms that can occur include headaches, dysfunction of the cranial nerves (the nerves that emerge directly from the brain), inflammation in the thyroid gland, sinus complications, runny nose, sneezing, swelling in various areas of the body, difficulty breathing, and enlarged kidneys.[3][13]
Prevention of IgG4-Related Disease
Because the exact cause of IgG4-related disease is unknown, there are currently no proven strategies to prevent the condition from developing. Unlike infectious diseases that can be prevented through vaccination or lifestyle-related conditions that can be avoided through behavioral changes, IgG4-RD cannot be prevented through any known measures.
However, early detection and prompt treatment can help prevent serious organ damage and complications. Since IgG4-RD can progress silently for months or years before causing noticeable symptoms, awareness of the disease is important. People who develop unexplained organ enlargement, tumor-like masses, or persistent symptoms affecting multiple organs should seek medical evaluation promptly.[3][10]
For patients already diagnosed with IgG4-RD, preventing disease flares and progression requires close follow-up with knowledgeable physicians and adherence to treatment plans. Regular monitoring through blood tests and imaging studies can help detect disease activity before significant damage occurs. Patients need to broaden their own knowledge of the condition and remain aware of symptoms and complications that can result from organ involvement.[3][10]
Smoking cessation is one lifestyle modification that may help patients with IgG4-RD. Smoking can worsen inflammation and increase complications related to the disease. Quitting smoking is one of the most effective steps patients can take to protect their organs and improve their overall health. Healthcare providers can offer support and resources to help patients quit smoking.[14]
Maintaining overall health through regular physical activity, mindful eating, and stress management may also be beneficial. While there is no specific “IgG4-RD diet,” making thoughtful food choices may help manage inflammation. A balanced diet with plenty of fruits, vegetables, whole grains, and lean proteins, while limiting fats and processed foods, is generally recommended for people with inflammatory conditions.[14]
Pathophysiology: How IgG4-RD Changes the Body
The pathophysiology of IgG4-related disease involves a series of abnormal immune responses that lead to characteristic changes in affected organs. Understanding these changes helps explain both how the disease damages the body and why certain treatments are effective.
The hallmark of IgG4-RD is the accumulation of immune cells, particularly lymphocytes and plasma cells, in affected tissues. Plasma cells are specialized white blood cells that produce antibodies. In IgG4-RD, there is a dense infiltration of these cells, many of which produce IgG4 antibodies. This infiltration is polyclonal, meaning it involves many different types of immune cells rather than a single clone, which helps distinguish IgG4-RD from cancerous conditions like lymphoma.[1][4]
A key feature seen under the microscope is storiform fibrosis, which is a specific pattern of scar tissue formation that looks like a cartwheel or storiform (mat-like) pattern. This distinctive scarring pattern is one of the characteristic findings that helps pathologists diagnose IgG4-RD. The fibrosis results from expansion of the extracellular matrix, which is the network of proteins and other molecules that provide structural support to tissues.[1][2][7]
Another important pathological feature is obliterative phlebitis, which involves inflammation and eventual destruction of veins within affected tissues. The inflammation causes the vein walls to become thickened and the vessel opening to become narrowed or completely closed off. This feature, along with storiform fibrosis, is seen in all affected tissues except bone marrow and lymph nodes, making these two sites less ideal for obtaining diagnostic tissue samples.[1][4][7]
The disease also frequently involves eosinophils, a type of white blood cell normally involved in allergic reactions and fighting parasites. The variable presence of eosinophils in affected tissues is another characteristic feature of IgG4-RD. Many patients have elevated numbers of eosinophils in their blood, a condition called eosinophilia.[1][4]
B cells, particularly those expressing the CD19 marker on their surface, play a central role in the disease process. These cells accumulate in affected tissues and are thought to drive inflammation both directly through the production of inflammatory proteins and indirectly by activating other immune cells called T cells. The lesions in IgG4-RD are rich in these CD19-positive B cells, which helps explain why treatments targeting B cells are often effective.[4][9]
Elevated levels of IgG4 in the blood are frequent in patients with IgG4-RD, though not universal. Some patients have normal IgG4 levels despite having active disease. Additionally, elevated IgG4 levels can occur in other conditions, so the blood test alone is not sufficient for diagnosis. The disease also commonly causes polyclonal hypergammaglobulinemia, which means there is a generalized increase in all types of antibodies in the blood, not just IgG4.[2][4]
The clinical manifestations of IgG4-RD—the tumor-like masses and organ enlargement—result from this dense tissue infiltration by immune cells and the expansion of scar tissue. Over time, affected organs can become filled with fibrosis, and if left untreated, this damage can become permanent. This is why early diagnosis and treatment are so important in preventing irreversible organ dysfunction.[2][5]
